| abstract |
COMPOUND, USE OF A COMPOUND, PHARMACEUTICAL COMPOSITION, AND, IN VIVO METHOD FOR MEASURING AMYLOID DEPOSITS IN AN INDIVIDUAL. The present invention relates to new heteroaryl substituted imidazopyridine derivatives, precursors thereof, and therapeutic uses of such compounds, having the structural formula (Ia) below: and its pharmaceutically acceptable salt, compositions and methods of use. In addition, the invention relates to new heteroaryl-substituted imidazopyridine derivatives that are suitable for imaging amyloid deposits in living individuals, their compositions, methods of use and processes for making such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in the brain in vivo to allow diagnosis prior to the death of Alzheimer's disease as well as measuring the clinical effectiveness of therapeutic agents for Alzheimer's disease. |